TDX/TDXFLX METHOTREXATE II 07A12-60

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01 report with the FDA on 2011-10-27 for TDX/TDXFLX METHOTREXATE II 07A12-60 manufactured by Abbott Diagnostics International Ltd.

Event Text Entries

[2220699] The customer stated that falsely decreased tflx methotrexate results were generated from a pediatric patient after infusion. A result of 4 umol/l was generated one hour after the infusion, was repeated at 3. 6 umol/l and reported out. The result was questioned and the sample was retested after manual dilution with an accepted result of 80 umol/l. Another result of 0. 02 umol/l was obtained 24 hours after the infusion. The result was reported out and questioned by the patient physician. The sample was then retested with an accepted result of 0. 79 umol/l. No impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[9368170] (b)(4). Product evaluation is in process and the results will be submitted in the final report once the evaluation is complete.
Patient Sequence No: 1, Text Type: N, H10


[18017914] Product evaluation was conducted to evaluate this issue. The lot search did not identify any atypical activity for the likely cause lot. Additionally no adverse trends or non-statistical trends were identified related to the issue under investigation. The abbott controls out of range protocol was performed for accuracy testing using likely cause lot 01222q101 and the testing met acceptance criteria. Based on this investigation tdxflx lot 01222q101 is performing as intended. No additional issues were identified and no product deficiency was identified related o the malfunction reported by the customer.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2623532-2011-00500
MDR Report Key2310853
Report Source01
Date Received2011-10-27
Date of Report2011-10-03
Date Mfgr Received2011-11-29
Date Added to Maude2012-01-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone847937-512
Manufacturer G1ABBOTT DIAGNOSTICS INTERNATIONAL LTD
Manufacturer StreetKM 58.0 CARRETERA 2 CRUCE DAVILA
Manufacturer CityBARCELONETA PA 00617
Manufacturer CountryUS
Manufacturer Postal Code00617
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTDX/TDXFLX METHOTREXATE II
Product CodeLAO
Date Received2011-10-27
Catalog Number07A12-60
Lot Number01222Q101
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT DIAGNOSTICS INTERNATIONAL LTD
Manufacturer AddressKM 58.0 CARRETERA 2 CRUCE DAVILA BARCELONETA PA 00617 US 00617


Patients

Patient NumberTreatmentOutcomeDate
10 2011-10-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.